Integrated BioPharma entered 2004 on a sound financial footing with good earnings and a healthy balance sheet.
Net sales (FY 2003): $22,235,306
Earnings per share: $0.09 (on 10.4 million shares outstanding)
Total assets: $20.8 million
Total liabilities: $2.6 million
External debt: $ 0
Working capital ratio: 7:1
